Die Radiofrequenzablation im Gallengang – Schritt für Schritt

Zur lokoregionären Tumorkontrolle hepatozellulärer und intrahepatischer cholangiozellulärer Karzinome ist die Radiofrequenzablation (RFA) ein bekanntes und etabliertes Verfahren. Seit einigen Jahren kommt sie nun auch zur Therapie maligner biliärer Strikturen und verschlossener Metallgitterstents zum Einsatz. Wie das geht und was es dabei zu beachten gilt, schildert dieser Beitrag.

Schlüsselwörter

Radiofrequenzablation - maligne Gallengangstenosen - Metallgitterstent - Komplikationen

• Literatur

• 1 Khan SA, Davidson BR, Goldin RD. et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: An update. Gut 2012; 61: 1657-1669
• 2 Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut 2007; 56: 1134-1152
• 3 Esnaola NF, Meyer JE, Karachristos A. et al. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer 2016; 122: 1349-1369
• 4 Moss AC, Morris E, Leyden J. et al. Malignant distal biliary obstruction: a systemic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 2007; 33: 213-221
• 5 Sangchan A, Kongkasame W, Pugkhem A. et al. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc 2012; 76: 93-99
• 6 Dumonceau JM, Tringali A, Blero D. et al. Biliary stenting: indications, choice of stents and results: European Society of Gastrointestinal ENDOSCOPY (ESGE) clinical guideline. Endoscopy 2012; 44: 277-298
• 7 Loew BJ, Howell DA, Sanders MK. et al. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter randomized controlled trial. Gastrointest Endosc 2009; 70: 284-289
• 8 Bruix J, Reig M, Sherman M. American evidence-based diagnosis staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 2016; 150: 835-853
• 9 Xu HX, Wang Y, Lu MD. et al. Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocacrcinoma. Br J Radiol 2012; 85: 1078-1084
• 10 Steel AW, Postgate AJ, Khorsandi S. et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc 2011; 73: 149-153
• 11 Kadayifci A, Atar M, Forcione DG. et al. Radiofrequency ablation for the management of occluded biliary metal stents. Endoscopy 2016; 48: 1096-1101
• 12 Camus M, Napoleon B, Vienne A. et al. Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: a multicenter prospective study. Gastrointest Endosc 2018; 88: 511-518
• 13 Itoi T, Isayama H, Sofuni A. et al. Evaluation of effects of a novel endoscopically applied radiofrequency ablation device. J patobiliary Pancreat Sci 2012; 19: 543-547
• 14 Sofi AA, Khan MA, Das A. et al. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systemic review and meta-analysis. Gastrointest Endosc 2018; 87: 944-951
• 15 Hansler J, Wissniowski TT, Schuppan D. et al. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J Gastroenterol 2006; 12: 3716-3721
• 16 Den Brok MH, Sutmuller RP, van der Voort R. et al. In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 2004; 64: 4024-4029
• 17 Tal AO, Vermehren J, Friedrich-Rust M. et al. Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. World J Gastrointest Endosc 2014; 6: 13-19